newsfilter
← Latest News
Business Wire·

Dicerna to Report Third Quarter 2021 Financial Results on Nov. 9, 2021

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) (the "Company" or "Dicerna"), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its third quarter 2021 financial results be